SMARCA4 and gastric cancer: FIRΔexon2 participates in the multi-step posttranscriptional regulation of BRG1, affecting epithelial–mesenchymal transition (EMT) via the BRG1/Snai1/E-cadherin pathway and promoting tumor proliferation and invasion in gastric cancers [46].